Subscribe to RSS
DOI: 10.1055/s-0038-1666895
Action of Brinase on Human Fibrinogen and Plasminogen
Publication History
Received 30 January 1978
Accepted 24 August 1978
Publication Date:
23 August 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/197901/lookinside/thumbnails/10-1055-s-0038-1666895-1.jpg)
Summary
Brinase added to human plasma in vitro caused a decrease in fibrinogen concentration, positive paracoagulation tests and formation of a friable clot in sequence. Agarose gel filtration of these samples revealed the presence of fibrinogen derivatives both larger and smaller than the parent molecule. Infusion of the enzyme in vivo resulted in a decreased fibrinogen level, a prolonged thrombin time and an increase in fibrinogen related antigen (FRA) in serum. The elution pattern of FRA in the plasma samples obtained after infusion of Brinase was similar to that of the in vitro samples. The plasma pool of fibrinogen was partially consumed by infusion of Brinase, but the turnover of plasminogen remained unaffected. Purified plasminogen was partially degraded by addition of the enzyme but this was not accompanied by a generation of proteolytic activity. These findings confirm that Brinase induces a proteolytic degradation of fibrinogen in plasma without activation of the plasminogen-plasmin system. Exposure of polymerization site(s) in the fibrinogen molecule is probably responsible for the reported clot promoting effect of the enzyme.
-
References
- 1 Bergkvist R. 1963; a The proteolytic enzymes of Aspergillus oryzae. III. A comparison of the fibrinolytic and fibrinogenolytic effects of the enzymes. Acta Chemica Scandinavica 17: 2230
- 2 Bergkvist R. 1963; b The proteolytic enzymes of Aspergillus oryzae. IV. On the inhibition of the enzymes by serum. Acta Chemica Scandinavica 17: 2239
- 3 Bergkvist R, Svard PO. 1964; Studies on the thrombolytic activity of a protease from Aspergillus oryzae. Acta Physiologica Scandinavica 60: 363
- 4 Blombäck B. 1958; On the properties of fibrinogen and fibrin. Arkiv för Kemi 12: 99
- 5 Bygdeman S. 1967; Effect of an Aspergillus enzyme on adenosine diphosphate (ADP) induced platelet aggregation and adhesiveness. Life Sciences 6: 499
- 6 Claeys H, Amery A, Verhaeghe R. 1971; Proteolytic activity of the activator produced by streptokinase in human plasma. Thrombosis et Diathesis Haemorrhagica 26: 88
- 7 Collen D, Tytgat G, Claeys H, Piessens R. 1972; a Metabolism and distribution of fibrinogen. I. Fibrinogen turn-over in physiological conditions in humans. British Journal of Haematology 22: 681
- 8 Collen D, Tytgat G, Claeys H, Verstraete M, Wallen P. 1972; b Metabolism of plasminogen in healthy subjects: Effect of tranexamic acid. Journal of Clinical Investigation 51: 1310
- 9 De Nicola P, Gibelli A, Turazza G, Giarola P. 1967; Influence of an Aspergillus enzyme on ADP-induced platelet aggregation and fibrinolysis. Life Sciences 6: 1233
- 10 Donati MB, Verhaeghe R, Culasso DE, Vermylen J. 1976; Molecular size distribution of fibrinogen derivatives formed in vitro and in vivo: a chromatographic study. Thrombosis and Haemostasis 16: 14
- 11 Frisch EP. 1974; Clinical review on Brinase, a protease from Aspergillus oryzae. Folia Haematologica 101: 63
- 12 Frisch EP, Blombäck M, Ekeström S, Kiessling H, Lund F, Magaard F. 1975; Dosage of I. V. Brinase in man based on inhibitor capacity and coagulation studies. Angiology 26: 557
- 13 Gormsen J, Feddersen C, Andersen RB. 1973; Degradation of human fibrinogen by Brinastase, trypsin and chromotrypsin. Scandinavian Journal of Haematology 10: 349
- 14 Gormsen J, Feddersen C. 1974; Degradation of non cross-linked and cross-linked fibrin clots by plasmin, trypsin, Chymotrypsin and Brinase. Thrombosis Research 5: 125
- 15 Jürgens J. 1966; Effect of an Aspergillus enzyme on platelet aggregation in humans. Life Sciences 5: 1379
- 16 Kiessling H, Svensson R. 1970; Influence of an enzyme from Aspergillus oryzae, Protease I, on some components of the fibrinolytic system. Acta Chemica Scandinavica 24: 569
- 17 Lindvall S, Magnussen O, Orth K. 1969; On the inhibition of a fibrinolytic enzyme from Aspergillus oryzae by serum. Acta Chemica Scandinavica 24: 569
- 18 Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. 1951; Protein measurement with the folin phenol reagent. Journal of biological Chemistry 193: 265
- 19 Lund F, Hellström L, Frisch EP. 1968; a Combined arteriography and regional thrombolytic therapy. Opuscula Medica. 13: 281
- 20 Lund F, Hellström L, Frisch EP. 1968; b Side effects observed in combined arteriography and regional thrombolytic therapy with Protease. Opuscula Medica 13: 396
- 21 Merskey C, Lalezari P, Johnson AJ. 1969; A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proceedings of the Society for Experimental Biology and Medicine 131: 871
- 22 Monkhouse FC, Daramola F, Gillespie RJ. 1964; The action of a proteolytic enzyme from Aspergillus oryzae on components of the blood clotting system. Canadian Journal of Physiology and Pharmacology 42: 377
- 23 Ogston O, Ogston CM. 1968; In vitro studies on a proteolytic enzyme from Aspergillus oryzae (Protease I). Thrombosis et Diathesis Haemorrhagica 19: 136
- 24 Palester-Chlebowczyk M, Stryzewska E, Sitkowski W, ölender A, Wegrzynowicz Z, Latallo ZS. 1971; Preliminary results of the protamine sulphate test in plasma of various patients. Scandinavian Journal of Haematology supplementum 13: 183
- 25 Roschlau WH E. 1964; The evaluation in the dog of a proteolytic enzyme derived from Aspergillus oryzae. Canadian Journal of Physiology and Pharmacology 42: 109
- 26 Roschlau WH E, Fisher AM. 1966; Thrombolytic therapy with local perfusions of CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Angiology 17: 670
- 27 Roschlau WH E, Gage R. 1972; The effects of Brinolase (fibrinolytic enzyme from Aspergillus oryzae) on platelet aggregation of dog and man. Thrombosis and Diathesis Haemorrhagica 28: 31
- 28 Roschlau WH E, Ives DA J. 1974; Review of the biochemistry and coagulation physiology of Brinolase: Folia Haematologica. 102: 22
- 29 Roschlau WH E, Tosoni AL. 1965; Thrombolytic therapy with Ca-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Canadian Journal of Physiology and Pharmacology 43: 731
- 30 Shainoff JR, Page IH. 1962; Significance of cryoprofibrin in fibrinogen-fibrin conversion. Journal of Experimental Medicine 116: 687
- 31 Svärd PO. 1966; The effect of an enzyme preparation from Aspergillus oryzae on the aggregation of rabbit platelets in vitro. Scandinavian Journal of Haematology 3: 277
- 32 Vermylen C, Devreker RH, Verstraete M. 1963; A quick quantitative enzymatic fibrinogen assay method: the fibrin polymerization time (FPT). Clinica Chimica Acta 8: 418
- 33 Vermylen J, Donati MB, Verstraete M. 1971; The identification of fibrinogen derivatives in plasma and serum by agarose gel filtration. Scandinavian Journal of Haematology supplement (Suppl. 13) 219